World Radiotherapy Awareness Day 14th November
Ground-breaking launch of WRAD
Oracle Head & Neck Cancer UK was proud to join the ground-breaking launch of World Radiotherapy Awareness Day (#WRAD2025), where 250+ global organisations united for a crucial cause.
As an organisation focused on head and neck cancers – which require the most complex radiotherapy treatments of any cancer type – the critical importance of sharing best practice and advancing radiotherapy access and awareness globally is critical.
The landmark sessions held on the 14th November 2024 bring together an unprecedented coalition:
- Radiation oncology professionals worldwide
- Patient advocates and carers
- Leading medical societies including @ESTRO_RT, @RCRadiologists, @ASTRO_org, @AORTIC_AFRICA, and @RANZCRcollege
- Industry innovators and healthcare leaders
WRAD’s 4 key missions
Together, there is an opportunity to shape #WRAD2025 with four key missions:
Raising awareness about radiotherapy’s vital role in cancer treatment
Fighting for equitable global access to advanced radiotherapy
Educating healthcare communities about modern treatment approaches
Celebrating the dedicated professionals who save lives daily
Why does this matter?
For head and neck cancer patients, access to advanced radiotherapy isn’t just important – it’s life-changing. These treatments require exceptional precision, expertise, and technology. Yet globally and even within the UK, there is very unequal access to this essential care.
This inaugural event marks the beginning of a powerful global movement. Through parallel sessions spanning time zones from Australia to the Americas and the in person event in London, we are working together to try and achieve a world where no cancer patient is denied the timely treatment they need.
Join us in this historic initiative as we work to transform the landscape of cancer care worldwide. Call outs to: Mehmet Sen, (LEEDS TEACHING HOSPITALS NHS TRUST), Katie Wakeham, (IMPERIAL COLLEGE HEALTHCARE NHS TRUST) and Tom Roques, Royal College of Radiologists
#WRAD#WRAD2025#RadiotherapyAwareness#HeadAndNeckCancer#CancerCare#GlobalHealth#Healthcare#Innovation#MedicalScience#PatientCare#OracleHNCUK
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced…
Theatre Meets Healthcare: Breaking Barriers in Cancer Conversations
In Leicester, theatre is transforming how Black communities talk about cancer. Oracle Head & Neck Cancer UK, alongside Theatre Sans Frontières, is using interactive Forum Theatre to tackle stigma, improve healthcare conversations, and break…
Jamie Theakston Announces He is Cancer-Free After Laryngeal Cancer Treatment
Heart Breakfast’s much-loved presenter, Jamie Theakston, has shared the incredible news that he is now cancer free! After completing treatment for stage one laryngeal cancer – cancer of the voice…
Mark Steele – Unforgettable evening of humour, resilience, and personal storytelling.
British comedian Mark Steele and military leader Major General Julian Buczacki are joining forces for an unforgettable evening of humour.
Revolutionising Head and Neck Cancer Care: The EVEREST-HN Project
Oracle HNCUK is thrilled to support the innovative EVEREST-HN project, a game-changing study led by The Royal Marsden. Now entering its feasibility trial phase, this groundbreaking research is set to transform…
Research Large Grants Programme Opportunity
We’re offering up to £300,000 over three years to support innovative, hypothesis-driven research projects.
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.